Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical diclofenac + capsaicin for acute back or neck pain
2015-000404-25Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of diclofenac and capsaicin in acute lumbago and neck pain (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change in pain on movement of worst procedure at Day 2 evening. Started Jan 2016; status: completed.
02
Drugs
diclofenaccapsaicin
03
Conditions
acute lumbagoneck pain
Beyond the preview
Go deeper on 2015-000404-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000404-25.